A University of Alabama at Birmingham-led team has found that mutations within five NF1 codons are linked to an increased likelihood of severe neurofibromatosis symptoms.
The HPOs will receive $13.8 million to enroll people interested in the All of Us program, gather participant health information, and help retain participants.
The grant will fund a collaboration investigating whether genomic signatures and other biomarkers can be used in clinical diagnosis and monitoring of kidney cancer.
The number of institutions offering clinical exome or genome tests to healthy individuals keeps increasing, but the practice remains controversial among medical experts.
The Alabama Genomic Health Initiative aims to recruit participants from every county in the state and provide genomic analysis and interpretation free of charge.
The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.
The agency has awarded five-year grants to three research institutions to promote education in genomic medicine among physicians and biomedical scientists.
Genome-wide association and other genetic studies hint at variants increasing subsequent neoplasm risk in individuals treated for cancer during childhood.
Their clinical trial will compare the effectiveness of tissue biopsies and liquid biopsies for tumor detection and monitoring.
A partnership with the Foundation for Mitochondrial Medicine and Seahorse Bioscience, the clinical program will evaluate Seahorse's XF Technology.
The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.
A small study finds differences between three genomic prostate cancer tests, Medscape reports.
In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.
A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.